Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CardiALLO by BioCardia for Systolic Heart Failure: Likelihood of Approval
CardiALLO is under clinical development by BioCardia and currently in Phase II for Systolic Heart Failure. According to GlobalData, Phase...